Abstract burst of orange and blue light particles

Efficient Project Management for a Late-Stage Parkinson’s Disease Study 

1 minute read

Published: January 6th, 2026

Phastar partnered with a biotechnology sponsor to manage statistical and data management activities for a late-stage clinical study in Parkinson’s disease. The project involved distributed teams, complex neurosurgical procedures, and questionnaire-driven endpoints—all under tight budget oversight. 

Key Challenges: 

  • Global team coordination across multiple time zones 
  • Limited internal statistical and data management expertise 
  • Complex CRF design for neurosurgical injections and questionnaire-based endpoints 
  • Need for strict oversight and cost control 

Our Approach: 

  • Scheduled cross-time-zone meetings to maximize participation and maintain momentum 
  • Provided clear, proactive explanations to support sponsor understanding at each stage 
  • Conducted detailed multidisciplinary reviews of complex CRF pages 
  • Ensured strict adherence to the project timeline to minimize rework and control budget impact 

Outcome: 

The study progressed smoothly, earning strong praise from all stakeholders. The sponsor commended Phastar’s professionalism, attention to detail, and proactive approach, noting significant improvements in collaboration, clarity, and project efficiency. 

Complete the form below to read the full case study

Related articles

From Rescue Study to Strategic Partnership: Accelerating Regulatory Submission Through Reliable Statistical Delivery

From Rescue Study to Strategic Partnership: Accelerating Regulatory Submission Through Reliable Statistical Delivery

November 16th, 2026 1 minute read

When clinical development programs face quality concerns, resource shortages, or submission risks, sponsors need a pa...

Turning a Failed Bioequivalence Study into a Successful Regulatory Outcome 

Turning a Failed Bioequivalence Study into a Successful Regulatory Outcome 

November 16th, 2026 1 minute read

When a bioequivalence study fails to meet regulatory criteria, understanding why is critical for successful developme...

Independent DMC Support and Interim Analysis for an ALS Clinical Trial 

Independent DMC Support and Interim Analysis for an ALS Clinical Trial 

November 16th, 2026 1 minute read

Data Monitoring Committees play a vital role in safeguarding patient safety and supporting informed decision-making t...